## Abstract ## Purpose: To investigate the targeting activity of the peptide (named P1c) derived from connective tissue growth factor (CTGF) to αvβ3‐rich tumor cells. ## Materials and Methods: P1c was synthesized and conjugated with ultrasuperparamagnetic iron oxide particles (USPIOs) coated wit
Bifunctional Ligands that Target Cells Displaying the αvβ3 Integrin
✍ Scribed by Robert M. Owen; Coby B. Carlson; Jinwang Xu; Patricia Mowery; Elisabetta Fasella; Laura L. Kiessling
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 343 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1439-4227
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The α~v~β~3~ integrin receptor ligand [^125^I]L‐775,219, **1c**, was synthesized for use in an __in vitro__ receptor binding assay with high specific activity (>1500 Ci/mmol) and a radiochemical yield of 15–20%. Conversion of iodide **1b** to the corresponding aryl trimethylstannane **2
## Abstract The interaction between the arginine glycine and aspartic acid motif (RGD) of integrin ligands such as vitronectin and the integrin receptor αVβ3 in mediating cell attachment has been well described. Similarly, the ability of disintegrins, small RGD containing peptides, to inhibit cell